Investment
Features
FeesSafety
Academy
More
Pluang+

Reserveage launches Longev+ supplement as Twinlab brands await cbdMD acquisition approval

Others
24 Sep 2026
PRNewsWire
View Source
Bullish
Reserveage launches Longev+ supplement as Twinlab brands await cbdMD acquisition approval

Reserveage, part of the Twinlab family, has launched Longev+, a new supplement combining amino acids, HMB, creatine, and resveratrol to support muscle health and healthy aging. Available exclusively at The Vitamin Shoppe, Longev+ targets adults seeking strength and vitality through all life stages. This launch aligns with Twinlab's focus on healthy aging and comes amid cbdMD's proposed acquisition of Twinlab brands, pending court approval. The acquisition aims to leverage Twinlab's brand strength with cbdMD's marketing and operational capabilities to expand in the wellness market.

Reserveage's Longev+ launch is the subject, with Pluang's Health-sector market snapshot as of Sep 24, 2026 19:31 WIB: out of 100 priced US health stocks, 40 rose and 55 fell. Notable movers include Biogen Inc (BIIB) at USD 223.67 with a -1.70% change and a typical hold time of 111 days, Oscar Health Inc (OSCR) at USD 30.05 with a -1.57% change and a 14-day hold time, and Ginkgo Bioworks Holdings Inc (DNA) at USD 8.46 with a -1.40% change, a 10-day hold time, and Pluang order activity showing 70% sell and 30% buy.

More News

Jefferies Q3 revenue seen up 8.1%, EPS slightly down; analyst optimism rising ahead of results

Jefferies Q3 revenue seen up 8.1%, EPS slightly down; analyst optimism rising ahead of results

Jefferies Financial Group is expected to report a third-quarter revenue of $2.21 billion, marking an 8.1% increase year-over-year, signaling strong sales growth. However, earnings per share (EPS) are forecasted to decline slightly by 1% to around $1....

Company Fundamentals
Neutral
2 hours ago
BMO lowers Paychex price target to $113 after mixed earnings and slowing sales growth

BMO lowers Paychex price target to $113 after mixed earnings and slowing sales growth

BMO Capital analyst Daniel Jester lowered the price target for Paychex to $113, reflecting caution despite the company's slight earnings beat with $1.63 billion revenue and $1.34 non-GAAP EPS. The stock dropped 8.77% as investors focused on lower GAA...

Analyst Insights
Bearish
3 hours ago
General Mills sees 3% sales drop but beats earnings estimates with strong international growth.

General Mills sees 3% sales drop but beats earnings estimates with strong international growth.

General Mills reported a 3% decline in sales to $4.40 billion, partly due to selling its U.S. yogurt business, causing adjusted gross margin to fall to 33.3%. Despite this, the company beat earnings expectations with adjusted EPS of $0.75, helped by ...

Market News
Neutral
3 hours ago
Okta's price target raised to $240 on strategic AI security shift, signaling 17% upside potential.

Okta's price target raised to $240 on strategic AI security shift, signaling 17% upside potential.

Jefferies raised Okta's price target from $200 to $240, reflecting a 16.87% potential gain as the company shifts focus to AI security. Okta aims to secure AI agents, a market CEO Todd McKinnon believes could outgrow traditional identity management. T...

Analyst Insights
Bullish
4 hours ago
Predict now offers continuous on-chain pricing with one-minute markets on Sui mainnet.

Predict now offers continuous on-chain pricing with one-minute markets on Sui mainnet.

Predict has integrated continuous on-chain pricing through the DeepBook App on the Sui mainnet, enabling prediction markets to operate with one-minute intervals. This is made possible by Sui's fast settlement capabilities, which allow for rapid marke...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App